Search

Novartis AG (NVS)

90.15
+0.91 (+1.02%)
Range89.69 - 90.274
52 week76.36 - 95.50
Open89.78
Vol/Avg.1,342,750
Mkt cap218.7B
P/E22.66
EPS3.938
Book/share29.011
Short ratio1.40
PEG1.79
EPS est.1.17

NVS additional information

Loading ...
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

NVS Profile

Exchange
NYSE
Sector
Executives
Dr. Daniel L. Vasella M.D.
Chairman and Member of Chairmans Committee

Mr. Joseph Jimenez MBA
Chief Exec. Officer

Mr. Jonathan R. Symonds C.B.E.
Chief Financial Officer

Mr. David Epstein B.Sc. B.A.
50
Division Head of Novartis Pharmaceuticals

Mr. George Gunn BVM&S SM
MRCVS. 61
Head of Animal Health and Head of Corp. Responsibility

Index Membership
Employee Count
126,000

Competitors

Ticker Last trade Change/%change P/E ratio  
NKTR 13.15 -0.10 / -0.75% -
QLTI 4.02 +0.02 / +0.50% -
SNY 54.02 +0.49 / +0.92% 27.06
MRK 57.61 +0.98 / +1.73% 29.84
PFE 29.11 +0.51 / +1.78% 17.96

NVS earnings
Brought To You By

Date
Actual
Expected
Prev Yr Qtr
1/27/2011
1.14
1.25
1.01
10/21/2010
1.27
1.20
0.92
1/26/2010
1.01
1.10
0.66